Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma

por Ishibashi, Mariko, Morita, Rimpei, Tamura, Hideto
Publicado 2021

Immunotherapy for Multiple Myeloma

por Tamura, Hideto, Ishibashi, Mariko, Sunakawa, Mika, Inokuchi, Koiti
Publicado 2019

PD-L1–PD-1 Pathway in the Pathophysiology of Multiple Myeloma

por Tamura, Hideto, Ishibashi, Mariko, Sunakawa-Kii, Mika, Inokuchi, Koiti
Publicado 2020

A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma treatment

por Moriya, Keiichi, Tamura, Hideto, Nakamura, Kyoko, Hosone, Masaru, Inokuchi, Koiti
Publicado 2016

Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells

por Moriya, Keiichi, Wakabayashi, Ayako, Shimizu, Masumi, Tamura, Hideto, Dan, Kazuo, Takahashi, Hidemi
Publicado 2010

CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia

por Kaito, Yuta, Hirano, Mitsuhito, Futami, Muneyoshi, Nojima, Masanori, Tamura, Hideto, Tojo, Arinobu, Imai, Yoichi
Publicado 2022

Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes

por Asayama, Toshio, Tamura, Hideto, Ishibashi, Mariko, Kuribayashi-Hamada, Yasuko, Onodera-Kondo, Asaka, Okuyama, Namiko, Yamada, Akiko, Shimizu, Masumi, Moriya, Keiichi, Takahashi, Hidemi, Inokuchi, Koiti
Publicado 2017

Clinical impact of serum soluble SLAMF7 in multiple myeloma

por Ishibashi, Mariko, Soeda, Saori, Sasaki, Makoto, Handa, Hiroshi, Imai, Yoichi, Tanaka, Norina, Tanosaki, Sakae, Ito, Shigeki, Odajima, Takeshi, Sugimori, Hiroki, Asayama, Toshio, Sunakawa, Mika, Kaito, Yuta, Kinoshita, Ryosuke, Kuribayashi, Yasuko, Onodera, Asaka, Moriya, Keiichi, Tanaka, Junji, Tsukune, Yutaka, Komatsu, Norio, Inokuchi, Koiti, Tamura, Hideto
Publicado 2018

P929: CIRCULATING TUMOR DNA ASSESSMENT IMPROVES PROGNOSTIC PREDICTION IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING IXAZOMIB, LENALIDOMIDE, AND DEXAMETHASONE

por Kogure, Yasunori, Handa, Hiroshi, Ito, Yuta, Ri, Masaki, Horigome, Yuichi, Iino, Masaki, Harazaki, Yoriko, Kobayashi, Takahiro, Abe, Masahiro, Ishida, Tadao, Ito, Shigeki, Iwasaki, Hiromi, Kuroda, Junya, Shibayama, Hirohiko, Sunami, Kazutaka, Takamatsu, Hiroyuki, Tamura, Hideto, Hayashi, Toshiaki, Akagi, Kiwamu, Shinozaki, Tomohiro, Yoshida, Takahiro, Mori, Ikuo, Iida, Shinsuke, Maeda, Takahiro, Kataoka, Keisuke
Publicado 2023